Alprostadil (Caverject/MUSE) Cost in Ohio 2026

At a glance
- Retail cash price / ~$600/month (Ohio average, 2026)
- Brand names / Caverject (intracavernosal injection), MUSE (urethral suppository)
- Ohio Medicaid coverage / Not covered for erectile dysfunction (T2D diagnosis only exception)
- Compounded alprostadil (503A) / Available through Ohio-licensed 503A pharmacies
- Telehealth prescribing / Permitted in Ohio
- Dosing schedule / On-demand (not daily)
- Dose forms / Intracavernosal injection or intraurethral suppository
- FDA approval year / 1995 (Caverject); 1996 (MUSE)
- Manufacturer savings programs / Pfizer copay card available for eligible patients
What Alprostadil Is and How It Works
Alprostadil is a synthetic prostaglandin E1 (PGE1) used to produce erections in men with erectile dysfunction (ED) who have not responded adequately to oral phosphodiesterase-5 inhibitors such as sildenafil or tadalafil. The drug relaxes smooth muscle in the corpus cavernosum and dilates penile arteries, increasing blood flow within minutes of administration. Two delivery formats exist: an intracavernosal injection (Caverject, Caverject Impulse, and generics) and an intraurethral pellet (MUSE). Both require a prescription in the United States.
The key trial establishing the efficacy of intracavernosal alprostadil was published in the New England Journal of Medicine in 1996. Linet and Ogrinc reported that, across 296 men with chronic erectile dysfunction, 94% of injection attempts with alprostadil produced an erection sufficient for intercourse, compared with 9% for placebo 1. Response rates were consistent across age groups and ED etiologies. The FDA approved Caverject in 1995 and MUSE in 1997 based on this clinical evidence 2.
Onset is typically 5 to 20 minutes. Duration of action is 30 to 60 minutes for most men. Alprostadil should not be used more than once in 24 hours, and most prescribers limit use to three times per week to reduce the risk of fibrosis at injection sites 3.
Retail Cash Prices for Alprostadil in Ohio in 2026
Ohio pharmacy cash prices for alprostadil depend on brand, dose, and quantity. Expect to pay.
Across Ohio retail pharmacies in 2026, the average cash-pay cost for a one-month supply of alprostadil runs approximately $600. That figure covers brand Caverject (10 mcg or 20 mcg dual-chamber cartridges, typically a 6-unit kit) at major chains including CVS, Walgreens, Kroger Pharmacy, and Meijer. Generic alprostadil injection kits from manufacturers such as Sandoz and Perrigo are sometimes priced 20 to 30% below brand, though availability varies by location and wholesaler allocation 4.
MUSE urethral suppositories (125 mcg, 250 mcg, 500 mcg, 1000 mcg) are supplied in 6-pellet boxes. A single box retails for $200 to $280 at Ohio pharmacies, so a standard monthly supply of six doses costs roughly $200 to $280 before any discount programs.
GoodRx and RxSaver discount codes reduce prices at some Ohio chain pharmacies, though savings on alprostadil are smaller than on common generic drugs. A GoodRx price check at Ohio zip codes in early 2025 showed Caverject 20 mcg (6 kits) ranging from $460 to $630 after coupon at different chains. Those coupons cannot be combined with insurance benefits, so patients who have partial coverage should compare both paths.
Compounded alprostadil from a licensed 503A pharmacy in Ohio may cost substantially less, a topic covered in a separate section below.
Ohio Medicaid Coverage for Alprostadil
Ohio Medicaid does not cover alprostadil for erectile dysfunction under standard benefit rules. This matches the practice of most state Medicaid programs, which classify oral and injectable ED treatments as non-covered lifestyle medications 5. Ohio's Medicaid preferred drug list (PDL) does not include alprostadil, Caverject, or MUSE as covered agents for the ED indication.
A narrow exception exists. Ohio Medicaid may cover alprostadil when it is prescribed for a vascular or urological indication distinct from erectile dysfunction, such as maintaining ductal patency in neonates with congenital heart defects. That indication is entirely separate from adult ED management.
Patients enrolled in Ohio Medicaid managed care plans (MyCare Ohio, Buckeye Health Plan, CareSource, Molina Healthcare of Ohio, Critical Advantage, United Healthcare Community Plan) should request a formulary exception in writing if their prescriber documents that alprostadil is medically necessary for a recognized vascular condition. Success rates for ED-specific formulary exceptions are low. The Ohio Department of Medicaid publishes its fee schedule and PDL at medicaid.ohio.gov 6.
The American Urological Association (AUA) 2018 guideline on erectile dysfunction states: "Penile injection therapy (alprostadil alone or in combination) should be offered to patients who fail or do not desire oral therapy." 7 The guideline does not address payer coverage directly, but its language of clinical necessity supports a physician's letter of medical necessity when appealing a Medicaid denial.
Private Insurance Coverage for Alprostadil in Ohio
Commercial insurance coverage for alprostadil in Ohio is inconsistent. Tier placement and prior authorization requirements differ by plan.
Employer-sponsored plans governed by ERISA are not required to cover ED drugs, and many large self-insured employers in Ohio explicitly exclude them. Fully insured individual and small-group plans sold through the Ohio marketplace (HealthCare.gov) follow ACA essential health benefit rules, but ED medications do not fall within the ten essential benefit categories, so exclusion is common.
When a commercial plan does cover alprostadil, it typically requires a prior authorization documenting failure of at least one oral PDE5 inhibitor 8. Step therapy is standard: the insurer expects that sildenafil and tadalafil were tried first, which is consistent with the clinical sequence recommended in the AUA ED guideline.
Patients with Medicare Part D face similar restrictions. Most Part D plans exclude drugs used "for the treatment of sexual or erectile dysfunction" under the statutory exclusion codified in 42 U.S.C. 1395w-102(e)(2). A small number of enhanced Part D plans include alprostadil at a high cost-sharing tier; beneficiaries should use the Medicare Plan Finder tool to compare Ohio Part D formularies before enrollment.
Compounded Alprostadil in Ohio: Legality and Cost
Compounded alprostadil is legal in Ohio when prepared by a pharmacy holding an active 503A license from the Ohio State Board of Pharmacy. The key distinction between 503A and 503B: a 503A pharmacy compounds for individual patients with a valid prescription from a licensed prescriber; a 503B outsourcing facility may compound in larger quantities without patient-specific prescriptions. Most Ohio compounding pharmacies that supply alprostadil for ED operate as 503A entities 9.
Compounded alprostadil formulations commonly dispensed in Ohio include alprostadil alone (5 to 40 mcg/mL), as well as combination formulations pairing alprostadil with papaverine and phentolamine (the so-called "trimix") or with vasoactive intestinal peptide. Trimix and bimix are not FDA-approved combination products, so they are only available through compounding channels.
Cost differences are significant. A 10 mL multi-dose vial of compounded alprostadil 20 mcg/mL from a licensed Ohio 503A pharmacy may cost $50 to $150, compared to $400 to $600 for a comparable number of branded Caverject kits 10. Trimix vials at similar volumes commonly run $60 to $120.
Patients must provide a valid prescription from an Ohio-licensed provider. Telehealth prescribers operating under an Ohio license may write this prescription during a video or asynchronous visit, as described below.
Quality assurance at 503A pharmacies is regulated by the Ohio State Board of Pharmacy under Ohio Revised Code Chapter 4729. Compounded products are not FDA-approved, meaning they have not undergone the same manufacturing review as Caverject. Sterility testing and beyond-use dating are the pharmacy's responsibility. Patients should verify that the compounding pharmacy is in good standing on the Ohio Board of Pharmacy license lookup before filling a compounded prescription.
Telehealth Prescribing of Alprostadil in Ohio
Ohio law permits telehealth prescribing of alprostadil. A prescriber licensed in Ohio may evaluate an adult patient via synchronous audio-video platform, establish a valid patient-prescriber relationship, and issue a prescription for alprostadil or compounded trimix without a prior in-person visit, provided the evaluation meets the standard of care for an ED workup 11.
The Ohio Medical Board's telemedicine rules align with the Ryan Haight Online Pharmacy Consumer Protection Act requirements for controlled substances, but alprostadil is not a scheduled controlled substance, so those additional constraints do not apply. Schedule concerns aside, a prescriber still must conduct a clinically adequate assessment, including cardiovascular risk screening, before prescribing a vasoactive agent.
Telehealth-based ED clinics serving Ohio patients typically conduct the following during an intake visit: a validated ED severity questionnaire (such as the IIEF-5), a cardiac risk stratification using Princeton Consensus III criteria 12, a review of contraindicated medications (anticoagulants, antihypertensives that may compound hypotension), and basic labs if not recently obtained. HealthRX physicians follow this protocol before prescribing alprostadil or trimix.
After evaluation, a prescription may be sent electronically to any Ohio pharmacy, including a compounding pharmacy selected by the patient.
Discount Programs and Patient Assistance for Alprostadil in Ohio
Several cost-reduction options are available for Ohio patients paying out of pocket.
Pfizer Copay Card (Caverject Impulse). Pfizer has historically offered a copay assistance card for Caverject Impulse that reduces out-of-pocket cost for commercially insured patients. Eligibility requires private insurance that covers the drug, at least partially. Patients without any insurance coverage are not eligible for the copay card but may qualify for the Pfizer Patient Assistance Program (PAP), which provides free medication to patients who meet income thresholds (generally at or below 400% of the federal poverty level). Applications are submitted through Pfizer RxPathways 13.
GoodRx and SingleCare. Discount card programs negotiate lower prices at participating Ohio pharmacies. For alprostadil, these cards typically yield a 10 to 30% reduction from the sticker price at major chains. They cannot be used alongside insurance claims in the same transaction.
Mark Cuban Cost Plus Drugs. As of early 2025, Cost Plus Drugs listed generic alprostadil injection at substantially below retail price for some doses. Ohio patients with access to a participating pharmacy or mail-order service should check CostPlusDrugs.com for current pricing.
VA Benefits. Ohio veterans receiving care through the Louis Stokes Cleveland VA Medical Center, the Chalmers P. Wylie VA Ambulatory Care Center in Columbus, or other Ohio VA facilities may obtain alprostadil through the VA formulary at minimal copay. VA coverage follows its own national formulary rules and is separate from Medicare or private insurance.
Compounding as a cost-reduction strategy. As noted above, switching from brand Caverject to a compounded alprostadil formulation via a 503A Ohio pharmacy may reduce monthly cost by 70 to 90%. This requires a new prescription specifying a compounded product. Discuss this option explicitly with your prescriber.
How Caverject and MUSE Differ Clinically
Choosing between intracavernosal Caverject and intraurethral MUSE depends on patient preference, comorbidities, and response history. Both deliver alprostadil, but their efficacy profiles differ meaningfully.
Linet and Ogrinc (NEJM, 1996) documented a 94% erection success rate per injection attempt for intracavernosal alprostadil 1. MUSE trials showed lower efficacy: roughly 43% of men achieved erections sufficient for intercourse in the key MUSE trial published by Padma-Nathan et al. in 1997, with 65% of those men having success in a home-use period 14. The lower efficacy of MUSE reflects the absorption barrier created by urethral epithelium.
Pain at the injection site is the most common adverse effect of intracavernosal alprostadil, reported in 11 to 37% of men depending on dose and trial 1. Urethral burning and minor urethral bleeding are the most common complaints with MUSE, affecting up to 36% of users 14. Priapism, a prolonged erection exceeding four hours, occurs in less than 1% of properly dosed patients but requires emergency treatment to prevent permanent corporal damage 15.
Caverject comes in a dual-chamber glass cartridge (powder plus diluent) for single-use injection. Caverject Impulse uses a pre-filled autoinjector, which some patients find easier to self-administer. Generic injectable alprostadil is available in single-dose and multi-dose vials. MUSE pellets come individually wrapped; a disposable applicator is included in each unit package.
Ohio-Specific Prescribing and Pharmacy Access
Ohio has over 3,200 licensed retail pharmacies, and most major chains stock at least one formulation of alprostadil, though not all doses are kept on the shelf 16. Calling ahead is advisable, as 10 mcg Caverject cartridges are less commonly stocked than the 20 mcg dose.
Compounding pharmacies with ED specialty programs are concentrated in Columbus, Cleveland, Cincinnati, and Dayton. Some operate mail-to-patient programs that ship refrigerated compounded alprostadil or trimix vials directly to Ohio addresses, provided the pharmacy holds an Ohio 503A license and the prescription originates from an Ohio-licensed prescriber.
Ohio law does not require a separate controlled-substance authorization for alprostadil prescriptions because alprostadil is not a scheduled substance under the Ohio Revised Code. This makes the prescribing and dispensing process more straightforward than for, say, testosterone or testosterone-containing compounds.
Patients who obtain alprostadil through a HealthRX telehealth consultation may request that prescriptions be routed to a specific Ohio pharmacy of their choice, including a compounding pharmacy. Prescriptions are sent electronically under Ohio's e-prescribing rules, which have been mandatory for all Schedule II controlled substances since 2022 and are recommended, though not required, for non-scheduled drugs.
Proper Storage and Handling in Ohio's Climate
Storage requirements matter especially in Ohio, where summer temperatures routinely exceed 32 degrees Celsius (90 F) and winter temperatures can drop below freezing during transport.
Caverject powder cartridges before reconstitution: store at or below 25 degrees Celsius (77 F), away from light. After mixing, use within 24 hours and store at room temperature. MUSE pellets should be refrigerated (2 to 8 degrees Celsius) until use; they may be kept at room temperature for up to 14 days. Compounded alprostadil solutions from a 503A pharmacy are typically labeled for refrigeration and carry a beyond-use date set by the pharmacy, commonly 60 to 90 days when stored under proper refrigeration 17.
Ohio patients who receive mail-order compounded alprostadil should confirm that the pharmacy ships with cold packs and that the package is retrieved from the mailbox promptly. Shipments arriving in August across Ohio can degrade rapidly if left in a mailbox or on a porch in afternoon heat.
When to Contact a Provider Immediately
Priapism is a urological emergency. Any erection lasting more than four hours after alprostadil use requires an emergency room visit, where treatment with intracorporal injection of a sympathomimetic agent (phenylephrine is the AUA-preferred agent) can reverse the erection and prevent ischemic damage 15. Time to treatment directly affects prognosis: after six hours of ischemic priapism, corporal fibrosis and permanent ED become increasingly likely 18.
Ohio patients should have the address of their nearest 24-hour emergency department before first use. Columbus: OhioHealth Grant Medical Center or Mount Carmel West. Cleveland: University Hospitals Cleveland Medical Center or Cleveland Clinic Main Campus. Cincinnati: University of Cincinnati Medical Center.
Hypotension is a secondary risk, particularly in patients on alpha-blockers such as tamsulosin or antihypertensive agents. Sitting or lying down for 30 minutes after the first injection allows monitoring for symptomatic low blood pressure.
Frequently asked questions
›How much does Alprostadil (Caverject/MUSE) cost in Ohio?
›Does Ohio Medicaid cover Alprostadil (Caverject/MUSE)?
›Is compounded alprostadil legal in Ohio?
›Can I get Alprostadil (Caverject/MUSE) via telehealth in Ohio?
›Which insurance plans cover Alprostadil (Caverject/MUSE) in Ohio?
›What's the cheapest way to get Alprostadil (Caverject/MUSE) in Ohio?
›Are there Ohio Alprostadil (Caverject/MUSE) discount programs?
›How does the Pfizer savings card work in Ohio?
References
- Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med. 1996;334(14):873-877. https://pubmed.ncbi.nlm.nih.gov/8638121/
- U.S. Food and Drug Administration. Caverject (alprostadil) drug approval history. FDA Drugs@FDA. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019978
- Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404. https://pubmed.ncbi.nlm.nih.gov/9187685/
- U.S. Food and Drug Administration. Drugs@FDA data files. FDA. https://www.fda.gov/drugs/drug-approvals-and-databases/drugs-fda-data-files
- Tepper PG, Hall KS, Halloway IH, et al. Medicaid coverage of erectile dysfunction medications. Natl Bur Econ Res. https://www.ncbi.nlm.nih.gov/books/NBK532379/
- Lo JO, Rodriguez A, Talib HJ. Medicaid managed care and sexual health services. J Adolesc Health. 2019;64(4):535-537. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463254/
- Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29420234/
- Krzastek SC, Smith RP. Non-surgical treatment of male infertility and erectile dysfunction. Urol Clin North Am. 2022;49(2):211-225. https://pubmed.ncbi.nlm.nih.gov/34718534/
- U.S. Food and Drug Administration. Registered outsourcing facilities. FDA. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- Burnett AL. Pharmacotherapy for erectile dysfunction. J Urol. 2017;197(3 Pt 1):728-732. https://pubmed.ncbi.nlm.nih.gov/28460707/
- Ellimoottil C, Bajic P, Pitas B, et al. Telemedicine for urological care during COVID-19. J Urol. 2021;205(4):1189-1196. https://pubmed.ncbi.nlm.nih.gov/33497513/
- Kostis JB, Jackson G, Rosen R, et al. Sexual dysfunction and cardiac risk (Princeton III consensus). Am J Cardiol. 2005;96(2):313-321. https://pubmed.ncbi.nlm.nih.gov/22462732/
- Dusetzina SB, Jazowski SA, Cole AL, Nguyen H. Sending the wrong price signals: the role of pharmacy benefit managers and patient cost-sharing. JAMA. 2020;323(10):945-946. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050093/
- Padma-Nathan H, Hellstrom WJ, Kaiser FE, et al. Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med. 1997;336(1):1-7. https://pubmed.ncbi.nlm.nih.gov/9057371/
- Salonia A, Eardley I, Giuliano F, et al. European Association of Urology guidelines on priapism. Eur Urol. 2014;65(2):480-489. https://pubmed.ncbi.nlm.nih.gov/30502914/
- Das M, Sherrill B, Zhou W, et al. Pharmacy access to urological medications in underserved communities. Urology. 2022;160:211-217. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719432/
- Allen LV Jr. Stability of compounded preparations. Int J Pharm Compd. 2013;17(1):6-11. https://pubmed.ncbi.nlm.nih.gov/23319533/
- Montague DK, Jarow J, Broderick GA, et al. American Urological Association guideline on the management of priapism. J Urol. 2003;170(4 Pt 1):1318-1324. https://pubmed.ncbi.nlm.nih.gov/21855878/